ContributorsPublishersAdvertisers

Roundtable Discussion: Mikhael Breaks Down Options for Long-term Treatment of Patients With Newly Diagnosed Multiple Myeloma

targetedonc.com
 2021-11-19

Cover picture for the articleA 51-year-old man presented with worsening fatigue on exertion and pallor with an ECOG performance score of 1. He eventually received a diagnosis of stage II standard-risk multiple myeloma after testing and examination. During a Targeted Oncology Case-Based Roundtable event, Joseph Mikhael, MD, professor, Applied Cancer Research and Drug...

www.targetedonc.com

Comments / 0

Comments / 0